99%Cagrilintide 10mg CAS 87805-34-3 Weight loss peptides Pure GLP-1 with safe deliverye...*
14 Inquiries
87805-34-3
Medical level
99%
shenzhen
YFS
BOX
2026-06-29
Retatrutide,Tirzepatize,MOTS-C,GHK-Cu,DSIP
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceGLP-1 stimulates pancreatic β cells to secrete insulin as an incretin hormone. GLP-1 also has additional actions, including suppression of glucagon secretion, inhibition of gastric motility, and promotion of satiety.
GLP-1 was first identified in the early 1980s, following the cloning of the proglucagon gene. The biological activity of GLP-1 was investigated initially by using the N-terminal extended forms of GLP-1(1–37 and 1–36 amide). However, these forms were devoid of biological activity. In the late 1980s, bioactive GLP-1 peptides were purified from gut extracts and were identified to be GLP1(7–37) and GLP-1(7–36)-amide. In the current literature, the unqualified designation of GLP-1 corresponds to the truncated peptides.
Glucagon-Like Peptide I (GLP1) is an incretin hormone, which functions as ligand for GLP1 receptors (GLP1R). These receptors are expressed in renal and cardiovascular system, such as smooth muscle and endothelial cells.
Glucagon Like Peptide-1 is a single, non-glycosylated, polypeptide chain containing 30 amino acids and having a molecular mass of 3297.7 Dalton.The GLP-1 is purified by proprietary chromatographic techniques.Basic Info-
Product Name:
GLP-1
Other Name:HIS-ASP-GLU-PHE-GLU-ARG-HIS-ALA-GLU-GLY- THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARGY-GLY;GLUCAGON-LIKE PEPTIDE I HUMAN;GLUCAGON-LIKE PEPTIDE-1, HUMAN;GLUCAGON-LIKE PEPTIDE I;GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN);GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT);GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT) TRIFLUOROACETATE SALT;GLP-1
CAS No.:87805-34-3
Molecular Formula:C186H275N51O59
InChIKeys:UKVFVQPAANCXIL-FJVFSOETSA-N
Molecular Weight:4169.48
EC Number:201-258-5
HScode:3504009000
Categories:
Characteristics-
Water Solubility:
Soluble to 5 mg/ml in water
Critical Temperature & Pressure:−20°C
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatize,MOTS-C,GHK-Cu,DSIP
-
Location:
6th Floor, Startup Incubation Center, No. 266 Nanhai Avenue, National High-Tech Industrial Development Zone, Haikou City, Hainan Province
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
12 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
-
Inquiry History14 Inquiries
Country Product Purchase Quantity Date Posted
United States
GLP -1
20 MG Oct 21, 2026
Canada
Glp-1
5 MT Sep 29, 2026
Philippines
GLP-1
10 MG Jul 23, 2026
Australia
GLP-1
1.00 G Jul 17, 2026
China
GLP-1
1.00 KG Jul 17, 2026
Philippines
GLP-1
15 MG Jul 14, 2026
United States
glp1
30 MG Jul 1, 2026
Thailand
GLP-3
300 MG Mar 10, 2026
United States
glp1
1 G Mar 10, 2026
United States
GLP-1
1 KG Feb 25, 2026
United States
GLP 3
20 MG Feb 24, 2026
United States
99% Purity Reta Lyophilized Powder GLP-1 for Weight Loss
20 L Jan 8, 2026
United States
glp1
1 KG Jan 5, 2026
United States
GLP-1
1 KG Jun 5, 2025 Post an enquiry for this product
More from this Seller
-
-
-
.Thymalin Customized Lyophilized Peptides CAS 79621-14-0 Thymalin Raw Powder Improve Cardiovascular System...
Medical level / 99%
$45-50/UNIT FOB
-
-
-
-
IGF-1 LR3/Pharmaceutical Grade IGF-1 LR3 Advanced Peptide for Scientific Studies
Medical level / 99%
$65-70/UNIT FOB
-